Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
481 Leser
Artikel bewerten:
(2)

American Screening Corporation: Ron Kilgarlin - Discusses a Broad Array of Home Drug Testing Products Offered by American Screening LLC

SHREVEPORT, LA / ACCESSWIRE / January 13, 2021 / The initial mission of American Screening LLC was to provide high-quality drug and alcohol screening products. In time, the company has grown into a main domestic and international manufacturer and distributor of diagnostic tests and essential medical supplies. The business received an ISO13485 contract, which helped it to expand its goal of supporting the fight against drug addiction and mental illness. As part of this commitment, American Screening LLC has made it one of its priorities to maintain a robust selection of home drug testing kits that are both highly accurate and affordably priced.

The most popular at-home drug tests are the ones using urine samples, primarily because they are easy and painless to run and deliver fast results. The kits offered by American Screening LLC can detect from one to as many as 40 drugs of abuse with an accuracy of up to 99%. As defined by the US Food and Drug Administration (FDA), "Drugs of abuse are illegal or prescription medicines (for example, Oxycodone or Valium) that are taken for a non-medical purpose. Non-medical purposes for a prescription drug include taking the medication for longer than your doctor prescribed it for or for a purpose other than what the doctor prescribed it for."

"At-home tests are among the most popular screening products because they allow people to conduct the procedure in a private setting without compromising on the accuracy of the results," American Screening LLC notes. "Our inventory includes kits that screen for a specific substance (typically marijuana) and others that can detect the presence of 2,5,6,10,11, or 12 drugs of abuse, including fentanyl, oxycodone, K2, ETG, cocaine, opiates, methamphetamine, amphetamines, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, ecstasy (MDMA), and oxycodone. In recent years, our tests have been increasingly sought out by parents due to rising illicit drug use among teenagers as part of a larger global trend sustained by the accessibility of synthetic drugs and the non-medical use of prescription medicines."

To ensure that its tests are properly run, American Screening LLC provides product inserts and procedure cards for every item listed on its website. In case a buyer still has difficulties running a test, the company's customer service team is readily available to answer any questions, and it has proved of immense help to countless people in need of additional assistance. Apart from being the distribution leader in the rapid diagnostic tests space, with over 250 million strips sold annually, American Screening LLC has remained firmly committed to offering personalized customer support to ensure that its clients receive the best possible product along with expert advice so that they can achieve their health and wellness goals.

Established in 2004 in Shreveport, Louisiana, American Screening LLC quickly garnered a strong reputation as its founder, Ron Kilgarlin, leveraged his expertise in business management, medical devices, product development, distribution, and marketing. Over the years, Ron built the company into a leading provider of diagnostic tests and medical supplies to the United States, South America, Asia, Africa, Europe, and Australia. American Screening LLC is the recipient of multiple certifications, including the highly coveted one issued under MDSAP (Medical Device Single Audit Program), which designates the company as compliant with the requirements for quality management systems in multiple jurisdictions.

American Screening, LLC - Leading Provider of Diagnostic Tests & Medical Supplies: http://americanscreeningcorporationnews.com

American Screening Corporation Enables Speedy and Efficient Decision-Making with Vast Selection of Rapid Drug Tests: https://news.yahoo.com/news/american-screening-corporation-enables-speedy-000000586.html

American Screening, LLC Now Offers COVID-19 Antibody Rapid Serology Tests: https://www.biospace.com/article/releases/american-screening-llc-now-offers-covid-19-antibody-rapid-serology-tests/

Contact Information:

Ron Kilgarlin
American Screening, LLC
9742 St Vincent Ave, Ste 100
Shreveport, LA 71106
1-866-526-2873
sales@americansreeningcorp.com
https://www.americanscreeningcorp.com

SOURCE: American Screening Corporation



View source version on accesswire.com:
https://www.accesswire.com/624184/Ron-Kilgarlin--Discusses-a-Broad-Array-of-Home-Drug-Testing-Products-Offered-by-American-Screening-LLC

© 2021 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.